DPART
Pharmacokinetic study of Dihydroartemisinin-Piperaquine (DP) in HIV-infected children on EFV-, LPV/r-, or DTG-based ART and HIV-uninfected children not on ART. All children will be malaria-uninfected.
Smile
Compares safety and antiretroviral effect of current standard ART to once daily intergrase inhibitor (INSTI) administered with darunavir/ritonavir (DRV/r) in HIV-1 infected, virologically suppressed children. This ongoing two arm, phase […]
Odyssey
A ViiV Health care funded randomised trial comparing efficacy and safety of dolutegravir (DTG)-based antiretroviral therapy (ART) versus standard of care (SOC) among HIV-infected children less than18years of age (≥3kg) […]
